Role of mesenchymal stem cells in hematopoietic stem cell transplantation
- PMID: 11055509
- DOI: 10.1097/00062752-200011000-00007
Role of mesenchymal stem cells in hematopoietic stem cell transplantation
Abstract
Within the bone marrow stroma are multipotential cells which are capable of differentiation into a number of mesenchymal cell lineages. These cells, termed mesenchymal stem cells, have recently been identified and characterized in humans. Many studies indicate that the bone marrow stroma is damaged following bone marrow transplantation. Since the marrow stroma is critical for the maintenance of hematopoiesis, its ability to support hematopoiesis following stem cell transplantation may be impaired. Animal models suggest that the transplantation of healthy stromal elements, including mesenchymal stem cells, may enhance the ability of the bone marrow microenvironment to support hematopoiesis after stem cell transplantation. Here the authors review recent data that suggest that mesenchymal stem cells may possess therapeutic value not only for the repair of damaged mesenchymal tissues following hematopoietic stem cell transplantation, but also as potential vectors for the delivery of corrective genes.
Similar articles
-
Mesenchymal stem cells: biology and potential clinical uses.Exp Hematol. 2000 Aug;28(8):875-84. doi: 10.1016/s0301-472x(00)00482-3. Exp Hematol. 2000. PMID: 10989188 Review.
-
Stromal cell lines from the aorta-gonado-mesonephros region are potent supporters of murine and human hematopoiesis.Exp Hematol. 2006 Nov;34(11):1505-16. doi: 10.1016/j.exphem.2006.06.013. Exp Hematol. 2006. PMID: 17046570
-
Marrow stem cells, mesenchymal progenitor cells, and stromal progeny.Cancer Invest. 2002;20(1):110-23. doi: 10.1081/cnv-120000372. Cancer Invest. 2002. PMID: 11852994 Review. No abstract available.
-
Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion.Exp Hematol. 2001 Feb;29(2):244-55. doi: 10.1016/s0301-472x(00)00635-4. Exp Hematol. 2001. PMID: 11166464
-
Mesenchymal stem cell: use and perspectives.Hematol J. 2003;4(2):92-6. doi: 10.1038/sj.thj.6200232. Hematol J. 2003. PMID: 12750726 Review.
Cited by
-
Mesenchymal stem cells and cancer therapy: insights into targeting the tumour vasculature.Cancer Cell Int. 2021 Mar 8;21(1):158. doi: 10.1186/s12935-021-01836-9. Cancer Cell Int. 2021. PMID: 33685452 Free PMC article. Review.
-
Study of oncogenic transformation in ex vivo expanded mesenchymal cells, from paediatric bone marrow.Cell Prolif. 2008 Dec;41(6):909-922. doi: 10.1111/j.1365-2184.2008.00559.x. Cell Prolif. 2008. PMID: 19040569 Free PMC article.
-
Bone marrow stromal cells from β-thalassemia patients have impaired hematopoietic supportive capacity.J Clin Invest. 2019 Feb 25;129(4):1566-1580. doi: 10.1172/JCI123191. eCollection 2019 Feb 25. J Clin Invest. 2019. PMID: 30830876 Free PMC article.
-
Mesenchymal Stromal Cells: Potential Option for COVID-19 Treatment.Pharmaceutics. 2021 Sep 16;13(9):1481. doi: 10.3390/pharmaceutics13091481. Pharmaceutics. 2021. PMID: 34575557 Free PMC article. Review.
-
The different immunoregulatory functions of mesenchymal stem cells in patients with low-risk or high-risk myelodysplastic syndromes.PLoS One. 2012;7(9):e45675. doi: 10.1371/journal.pone.0045675. Epub 2012 Sep 21. PLoS One. 2012. PMID: 23029178 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
